UnitedHealth's strong Q1 boosts Wall Street confidence

UnitedHealth's robust Q1 results have bolstered Wall Street's confidence in the healthcare giant. On April 21, UnitedHealth Group (UNH) reported strong first-quarter earnings, surpassing analysts' expectations for both earnings and revenue. The company also raised its full-year profit guidance to at least $18.25 per share. This performance comes after a period of struggle, during which Warren Buffett bought UNH stock, indicating his faith in the company's long-term prospects.

The positive results have driven UNH's stock price higher and boosted investor confidence in the broader healthcare sector. UnitedHealth's stock surged post-earnings, pushing its relative strength index (RSI) into overbought territory. This momentum has spilled over to other healthcare stocks, with the Health Care Select Sector SPDR Fund (XLV) also trading higher.

Investors should watch for UnitedHealth's full-year performance and potential changes in healthcare policy. Upcoming catalysts include UnitedHealth's next earnings release, scheduled for July 21, and any developments related to healthcare policy under the new U.S. administration. These factors will help determine if the recent bullish sentiment around UNH is sustained or if the stock becomes due for a pullback.